You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康泰生物(300601.SZ):23價肺炎球菌多糖疫苗獲得烏茲別克斯坦註冊證
格隆匯 09-30 19:55

格隆匯 9 月 30日丨康泰生物(300601.SZ)公佈,近日,公司全資子公司北京民海生物科技有限公司獲得烏茲別克斯坦共和國(“烏茲別克斯坦”)頒發的藥品註冊證,註冊產品為23價肺炎球菌多糖疫苗;包裝規格:西林瓶,0.5ml/瓶;有效期:5年。

此次獲得烏茲別克斯坦藥品註冊證書,是公司國際化取得又一里程碑式進展,有利於提高公司的知名度和影響力,對公司國際市場的開拓產生積極影響,符合公司“走出去”的發展戰略。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account